Caldera Therapeutics
Caldera was founded in 2025 to advance innovative biologics in IBD, assembling a senior leadership team with deep experience in the discovery and development of IBD therapeutics and a proven track record of building biotechnology companies through to successful exits. Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Caldera Therapeutics use?+
Caldera Therapeutics uses 10 technologies including Adobe Fonts, Squarespace, Squarespace Commerce.
What industry is Caldera Therapeutics in?+
Caldera Therapeutics operates in the Biopharma industry.
Where is Caldera Therapeutics based?+
Caldera Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026